We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32B
AUM Growth
+$6.48B
Cap. Flow
+$4.77B
Cap. Flow %
14.9%
Top 10 Hldgs %
10.84%
Holding
2,554
New
720
Increased
686
Reduced
602
Closed
529

Sector Composition

Rank Sector Weight
1 Financials 20.47%
2 Consumer Discretionary 12.5%
3 Healthcare 10.55%
4 Industrials 6.63%
5 Real Estate 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSBF icon
1626
Waterstone Financial
WSBF
$375M
$400K ﹤0.01%
23,466
-5,500
-19% -$103K
GRPN icon
1627
Groupon
GRPN
$955M
$399K ﹤0.01%
3,917
-15,611
-80% -$1.64M
NWSA icon
1628
News Corp Class A
NWSA
$16.1B
$399K ﹤0.01%
24,600
-40,425
-62% -$605K
MDSO
1629
DELISTED
Medidata Solutions, Inc.
MDSO
$399K ﹤0.01%
+6,300
New +$449K
TGNA
1630
DELISTED
TEGNA Inc
TGNA
$398K ﹤0.01%
28,263
-27,125
-49% -$355K
VGR
1631
DELISTED
Vector Group Ltd.
VGR
$398K ﹤0.01%
27,663
-10,165
-27% -$141K
CTT
1632
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$396K ﹤0.01%
30,160
+18,948
+169% +$245K
EIG icon
1633
Employers Holdings
EIG
$908M
$395K ﹤0.01%
8,904
+3,752
+73% +$177K
EVTC icon
1634
Evertec
EVTC
$1.85B
$395K ﹤0.01%
28,918
-41,663
-59% -$590K
PGEN icon
1635
Precigen
PGEN
$2.47B
$394K ﹤0.01%
+34,177
New +$509K
RC
1636
Ready Capital
RC
$279M
$394K ﹤0.01%
25,975
-8,700
-25% -$137K
CALA
1637
DELISTED
Calithera Biosciences, Inc
CALA
$394K ﹤0.01%
2,360
+1,670
+242% +$428K
CONE
1638
DELISTED
CyrusOne Inc Common Stock
CONE
$394K ﹤0.01%
6,626
-55,771
-89% -$3.38M
CXRX
1639
DELISTED
Concordia International Corp. Common Stock
CXRX
$388K ﹤0.01%
590,000
BRSL
1640
Brightstar Lottery PLC
BRSL
$2.03B
$386K ﹤0.01%
14,566
-2,627,199
-99% -$67.3M
FN icon
1641
Fabrinet
FN
$19.5B
$382K ﹤0.01%
13,300
+1,100
+9% +$36.4K
GHC icon
1642
Graham Holdings Company
GHC
$5.06B
$382K ﹤0.01%
685
+200
+41% +$113K
BFX
1643
DELISTED
BowFlex Inc.
BFX
$382K ﹤0.01%
+28,624
New +$414K
MRTN icon
1644
Marten Transport
MRTN
$1.21B
$379K ﹤0.01%
+27,996
New +$366K
SPNT icon
1645
SiriusPoint
SPNT
$2.75B
$379K ﹤0.01%
+25,859
New +$416K
WT icon
1646
WisdomTree
WT
$3.26B
$378K ﹤0.01%
30,100
-529,410
-95% -$6.08M
CNCE
1647
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$377K ﹤0.01%
14,565
+3,000
+26% +$60.4K
EME icon
1648
Emcor
EME
$35.7B
$375K ﹤0.01%
4,582
-4,450
-49% -$345K
HMTV
1649
DELISTED
Hemisphere Media Group, Inc.
HMTV
$375K ﹤0.01%
32,469
+1,100
+4% +$13K
GBDC icon
1650
Golub Capital BDC
GBDC
$3.39B
$374K ﹤0.01%
+20,963
New +$388K

Similar funds

Balyasny Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Balyasny Asset Management held 2,554 positions worth $32B, up 25% from $25.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management deployed $4.77B of net new capital in Q4 2017, opening 720 new positions and adding to 686 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was American Express, an estimated $253M trimmed.

  • Balyasny Asset Management's largest Q4 2017 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
  • Balyasny Asset Management added most to Aetna Inc in Q4 2017, an estimated $175M increase.
  • Balyasny Asset Management's biggest Q4 2017 reduction was American Express, cutting an estimated $253M.
  • Balyasny Asset Management fully exited Range Resources in Q4 2017, selling an estimated $104M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $32B portfolio in Q4 2017.
  • Balyasny Asset Management opened 720 new positions and closed 529 in Q4 2017.
  • Balyasny Asset Management's portfolio value rose 25% quarter-over-quarter to $32B.

Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.